1,2,3,4,6-Pentagalloyl Glucose, a RBD-ACE2 Binding Inhibitor to Prevent SARS-CoV-2 Infection

The outbreak of SARS-CoV-2 virus caused more than 80,155,187 confirmed COVID-19 cases worldwide, which has posed a serious threat to global public health and the economy. The development of vaccines and discovery of novel drugs for COVID-19 are urgently needed. Although the FDA-approved SARS-CoV-2 v...

Full description

Bibliographic Details

Published in:	Frontiers in Pharmacology
Main Authors:	Rui Hong Chen, Li Jun Yang, Sami Hamdoun, Sookja Kim Chung, Christopher Wai-kei Lam, Kai Xi Zhang, Xiaoling Guo, Chenglai Xia, Betty Yuen Kwan Law, Vincent Kam Wai Wong
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2021-03-01
Subjects:	1, 2, 3, 4, 6-pentagalloyl glucose RBD-ACE2 inhibitor SARS-CoV-2 COVID-19 viral infection
Online Access:	https://www.frontiersin.org/articles/10.3389/fphar.2021.634176/full